Senior Director, Global Analytics & Insights, Cell Therapy

AstraZeneca•Santa Monica, CA
•$218,330 - $327,494

About The Position

The Senior Director, Global Analytics & Insights, Cell Therapy leads insights and analysis for AstraZeneca’s Cell Therapy Enterprise, supporting priority assets from clinical development through commercialization across prioritized disease areas. The role provides deep insights and strategic direction for enterprise-level initiatives and key commercial decisions, and serves as the Global Analytics & Insights point of contact for the Cell Therapy Enterprise. It reports to the Global Commercial Head, Cell Therapy. The position partners with enterprise leadership, priority markets, and cross-functional teams to shape portfolio strategy, asset development plans, and long-range business planning. It builds understanding of disease areas, patients, healthcare professionals, market dynamics, competitors, and implications for AstraZeneca’s portfolio. The role develops evidence and market understanding to support clinical development, asset prioritization, indication strategy, and future commercialization. For priority assets and indications, the role integrates clinical, market, customer, competitor, access, and treatment-delivery insights to inform target product profiles, development choices, indication sequencing, portfolio prioritization, and forecasts. It develops quantitative analyses and business cases accounting for cell therapy considerations such as eligible patient identification, referral pathways, treatment-center readiness, manufacturing capacity, vein-to-vein time, access, and scalability. It also manages external market research, forecasting, and data/analytics vendor relationships and budgets, and explores advanced analytics and predictive modeling suited to cell therapy’s delivery model.

Requirements

  • Bachelor’s degree in a relevant scientific or mathematics discipline.
  • At least 6 years of analytical and market research experience in the pharmaceutical or consulting industry.
  • Excellent communication skills.
  • Experience engaging and communicating with senior executives.
  • Experience in a similar strategy role within the pharmaceutical industry or life science consulting.
  • Ability to use data and analysis to affect, influence, or change understanding of a market or customer.

Nice To Haves

  • MBA, PhD, PharmD, or another advanced degree.
  • Cell therapy, advanced therapies, or oncology development experience (strongly preferred).
  • At least 4 years of experience at a consulting, advisory, or investment firm working within the pharmaceutical industry.
  • Experience supporting early-stage or pre-launch assets, including indication prioritization, target product profile development, forecasting under uncertainty, and commercialization readiness.
  • Experience working in a global team.

Responsibilities

  • Act as the Global Analytics & Insights point of contact for the Cell Therapy Enterprise, partnering with cross-functional leaders and priority markets on portfolio strategy, asset development plans, and long-range business planning.
  • Build knowledge of key disease areas, including healthcare professional and patient insights, market dynamics, competitive landscape, and implications for the AstraZeneca portfolio.
  • Lead strategic projects across the cell therapy portfolio with enterprise leadership and cross-functional teams.
  • Build capabilities, evidence, and market understanding to support clinical development plans, asset prioritization, indication strategy, and future commercialization.
  • Develop deep therapy-area knowledge spanning clinical development through commercialization for priority assets and indications.
  • Develop strategic understanding of patients, markets, collaborators, competitors, and brands to drive competitive advantage.
  • Partner with Global Commercial, R&D, Medical, Regulatory, Market Access, and Operations teams, bringing objective insights to asset and portfolio decisions.
  • Provide an independent, external, and future-oriented perspective in decision-making bodies.
  • Integrate clinical, market, customer, competitor, access, and treatment-delivery insights to inform target product profiles, development choices, indication sequencing, portfolio prioritization, and opportunity-focused forecasts.
  • Develop quantitative analyses and business cases that account for cell therapy-specific factors, including eligible patient identification, referral pathways, treatment-center readiness, manufacturing capacity, vein-to-vein time, access, and scalability.
  • Manage relationships and budgets with external market research, forecasting, and data/analytics vendors and partners.
  • Explore advanced analytics and predictive modeling suited to cell therapy’s unique delivery model.

Benefits

  • Qualified retirement program (401(k) plan)
  • Paid vacation and holidays
  • Paid leaves
  • Medical coverage
  • Prescription drug coverage
  • Dental coverage
  • Vision coverage
  • Short-term incentive bonus opportunity
  • Eligibility to participate in an equity-based long-term incentive program (salaried roles)
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service